Stating that the delay in approval for Oxford-AstraZeneca COVID-19 vaccine - being mass produced by his company - was not worrying, Serum Institute of India's (SII) Adar Poonawalla said the inoculant is likely to get a go-ahead in the United Kingdom "by end of this December or by early January".